Residency · Chicago, IL
Sponsored by University of Illinois College of Medicine at Chicago
International Classification of Retinopathy of Prematurity, Third Edition.
Ophthalmology · 2021 · 659 citations · Michael Blair
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Ophthalmology · 2024 · 192 citations · Jennifer Lim
TFOS DEWS III: Digest.
American journal of ophthalmology · 2025 · 110 citations · Dimitri Azar
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Lancet (London, England) · 2023 · 299 citations · Veeral Sheth
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
Ophthalmology · 2021 · 375 citations · Brian Joondeph
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results.
Eye (London, England) · 2023 · 157 citations · Veeral Sheth
ChatGPT and Ophthalmology: Exploring Its Potential with Discharge Summaries and Operative Notes.
Seminars in ophthalmology · 2023 · 125 citations · Ali Djalilian
Ethical considerations regarding animal experimentation.
Journal of preventive medicine and hygiene · 2022 · 218 citations · Paul Sieving